Skip to content

Ultrasonography Screening for Breast Lesions During Pregnancy and Lactation

Ultrasonography Screening for Breast Lesions During Pregnancy and Lactation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05568628
Enrollment
50
Registered
2022-10-05
Start date
2022-11-30
Completion date
2024-06-30
Last updated
2022-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preganat and Lactating Faemls

Brief summary

All breast disorders found during pregnancy and lactation should be carefully evaluated. Most of them are benign e.g., lactating adenoma, galactocele, fibroadenoma or inflammatory disorders e.g., mastitis, abscess formation, granulomatous mastitis, but it is essential to exclude pregnancy-associated breast cancer (PABC), which is too often diagnosed late Ultrasound is the first line breast imaging technique during pregnancy and lactation as Development of alveoli during pregnancy might not occur symmetrically, and these can be felt as focal nodularities, or even feel similar to masses, any suspicion of a mass should be assessed with US . If US illustrates glandular tissue and this correlates with the examiner presumption, no further work-up needs to be done. However, if presence of a mass is highly assumed, further follow-up by mammography, MRI and biopsy, when necessary, must be performed

Interventions

DEVICEultrasound

screening of breast lesions by ultrasonography

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant and lactating women with or without complaining of breast pain or breast lump referred from Obstetric and Gynecological outpatient clinic or surgery outpatient clinic

Exclusion criteria

* Non pregnant, non-lactating females, females with previous breast surgery or breast mass lesions before pregnancy or lactation.

Design outcomes

Primary

MeasureTime frameDescription
percent of breast lesions in pregnant and lactating females'12 monthpercent of breast lesions in pregnant and lactating females'

Countries

Egypt

Contacts

Primary Contactheba G ahmed, resident doctor
hebatallah_07649@med.sohag.edu.eg01067986223
Backup ContactMohamed Z ali, professor
01001119166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026